Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 21.85
-1.14 (-4.96%)
At close: Jul 31, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 313.61 million as of July 31, 2026. Its market cap has decreased by -41.86% in one year.
Market Cap
313.61M
Enterprise Value
307.93M
Revenue
n/a
Ranking
n/a
PE Ratio
19.68
Stock Price
21.85
ChartMarket Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 313.61M, an increase of 1,338.52%. That is a compound annual growth rate of 14.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 313.61M | -38.69% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Auro Laboratories | 1.44B |
| Smruthi Organics | 1.29B |
| Tyche Industries | 1.25B |
| Krebs Biochemicals & Industries | 1.16B |
| Vasundhara Rasayans | 562.22M |
| Crestchem | 381.15M |
| Alfavision Overseas (India) | 378.00M |
| Ishita Drugs and Industries | 225.08M |